ProCE Banner Activity

New Criteria, New Hope: Rethinking When to Start Second-line Therapy for PBC

Clinical Thought

New insights from AASLD 2024 show how criteria for second-line therapy for PBC could reshape treatment approaches in the effort to improve patient outcomes.

Released: December 17, 2024

Expiration: December 16, 2025

Share

Faculty

Sonal Kumar

Sonal Kumar, MD, MPH

Director, Clinical Gastroenterology and Hepatology
Assistant Professor of Medicine
Weill Cornell Medical College
New York, New York

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Gilead Sciences, Inc. and Ipsen Biopharmaceuticals, Inc.

Gilead Sciences, Inc.

Ipsen Biopharmaceuticals Inc